Masson Kristina 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Masson Kristina
DirectorEVP - Business Operations
Transactions
- Award
Common Stock
2022-11-14+26,707→ 320,705 total - Award
Stock Option (Right to Buy)
2022-11-14+80,120→ 80,120 totalExercise: $12.50Exp: 2032-11-13→ Common Stock (80,120 underlying) - Award
Common Stock
2022-11-14+934,731→ 1,806,588 total(indirect: See footnote) - Award
Common Stock
2022-11-14+503,419→ 2,310,007 total(indirect: See footnote) - Award
Common Stock
2022-11-14+60,090→ 2,370,097 total(indirect: See footnote) - Award
Stock Option (Right to Buy)
2022-11-14+180,269→ 180,269 total(indirect: See footnote)Exercise: $12.50Exp: 2032-11-13→ Common Stock (180,269 underlying)
Footnotes (6)
- [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, twenty-five percent (25%) of the RSUs shall vest on the one-year anniversary of the grant date, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
- [F2]These shares represent RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. This RSU grant to the Reporting Person's spouse constitutes a number of shares equal to 3.5% of the total outstanding shares of the Issuer as of the pricing of the Issuer's initial public offering, on a fully diluted basis after giving effect to the offering.
- [F3]These securities are held by Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.
- [F4]These shares represent RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. This RSU grant to the Reporting Person's spouse constitutes a number of shares equal to 1.885% of the total outstanding shares of the Issuer as of the pricing of the Issuer's initial public offering, on a fully diluted basis after giving effect to the offering, meant to cover estimated tax liability at the time of settlement of the RSU award referred to in footnote 2.
- [F5]These shares represent RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F6]Twenty-five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the grant date, and the remaining shares subject to the option shall vest in 36 equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.